14 Jun 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

Change in the Board of Directors of FluoGuide


January 25, 2021

Copenhagen, Denmark, 25 January 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) announces that the chairman of the Board of Directors, Arne Ferstad, will not stand for re-election at the upcoming Annual General Meeting

Arne Ferstad, the Chairman of the Board of Directors, has notified FluoGuide that he will not stand for re-election at the upcoming annual general meeting on the 9th of February, 2021, for personal reasons.

“I would  like to thank Arne for his great contribution to FluoGuide since the very beginning. It has been a pleasure working together with Arne over these last years, and  I wish him the very best” says Morten Albrechtsen, CEO.

The other members of the Board of Directors are Lisa Micaela Sjokvist, Shomit Ghose, Peter Mørch Eriksen and Andreas Kjær, who are all proposed to be re-elected at the Annual General Meeting on the 9th of February 2021.

This disclosure contains information that Fluoguide is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 25-01-2021 13:55 CET.